Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

A major change in the way HHS plans to evaluate vaccine safety is raising fears that approvals will become unnecessarily ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Nova ...

Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns ...